Literature DB >> 20096082

Use of antifungal agents for oral candidiasis: results of a national survey.

Y Martínez-Beneyto1, P López-Jornet, A Velandrino-Nicolás, V Jornet-García.   

Abstract

BACKGROUND: Candida albicans is an opportunistic agent that colonizes the oral mucosa.
OBJECTIVES: To determine the attitude of Spanish dentists toward the oral treatment of candidiasis.
METHOD: Between May and November 2006, a questionnaire was circulated to a random selection of 1134 dentists obtained from the General Dental Council's main list. The survey consisted of a block of socio-demographic items followed by another block related to the diagnosis and treatment of oral candidiasis. Replies to the questionnaire were received from 840 (74%) dentists.
RESULTS: 50.4% of respondents were men, and 48.1% were female with a mean age of 38 and 12.2 years of professional experience. Miconazole was the most popular choice of antifungal agent prescribed (59.3%), followed by nystatin (57.7%) for topical use. Systemic antifungal agents were used by 30.20% of dentists, with a strong association between their use and the number of years in practice, gender and professional qualifications (P < 0.005).
CONCLUSION: Most Spanish dentists make clinical diagnosis and treat oral infections by C. albicans themselves with topical drugs (miconazole and nystatin) as a first choice. Systemic treatments are more commonly chosen by male dentists with long professional experience, especially by stomatologists.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096082     DOI: 10.1111/j.1601-5037.2008.00357.x

Source DB:  PubMed          Journal:  Int J Dent Hyg        ISSN: 1601-5029            Impact factor:   2.477


  6 in total

1.  Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4.

Authors:  Juha Grönlund; Teijo I Saari; Nora Hagelberg; Pertti J Neuvonen; Klaus T Olkkola; Kari Laine
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

2.  Mucoadhesive bilayered buccal platform for antifungal drug delivery into the oral cavity.

Authors:  Burcum Uzunoğlu; Clive G Wilson; Meral Sağıroğlu; Selin Yüksel; Sevda Şenel
Journal:  Drug Deliv Transl Res       Date:  2021-02       Impact factor: 4.617

3.  Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan.

Authors:  Mohammad H Al-Shayyab; Osama A Abu-Hammad; Mahmoud K Al-Omiri; Najla S Dar-Odeh
Journal:  Int Dent J       Date:  2015-07-07       Impact factor: 2.607

4.  Effect of Denture-Related Stomatitis Fluconazole Treatment on Oral Candida albicans Susceptibility Profile and Genotypic Variability.

Authors:  Maria Helena Figueiral; Patrícia Fonseca; Maria Manuel Lopes; Eugénia Pinto; Teresa Pereira-Leite; Benedita Sampaio-Maia
Journal:  Open Dent J       Date:  2015-01-30

5.  Current treatment of oral candidiasis: A literature review.

Authors:  Carla Garcia-Cuesta; Maria-Gracia Sarrion-Pérez; Jose V Bagán
Journal:  J Clin Exp Dent       Date:  2014-12-01

6.  In Vitro Antifungal Susceptibility of Candida Species Isolated from Iranian Patients with Denture Stomatitis.

Authors:  Saeid Mahdavi Omran; Maryam Rezaei Dastjerdi; Maryam Zuashkiani; Vahid Moqarabzadeh; Mojtaba Taghizadeh-Armaki
Journal:  Biomed Res Int       Date:  2018-05-16       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.